Showing 1211-1220 of 4012 results for "".
Sniffing Out the Problem: A Dive into Management for Chronic Rhinosinusitis with Nasal Polyps
https://reachmd.com/programs/cme/sniffing-out-problem-dive-management-chronic-rhinosinusitis-nasal-polyps/11071/For the 20% of patients with chronic rhinosinusitis who develop nasal polyps, identifying the underlying cause is essential for treatment.Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
https://reachmd.com/programs/cme/optimizing-the-role-for-corticosteroids-within-the-evolving-dmd-treatment-landscape/37232/Navigate corticosteroid use in DMD: Compare options, manage side effects, and align treatment with advanced therapies.From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
https://reachmd.com/programs/cme/from-late-line-rescue-to-early-line-option-the-potential-for-bispecific-antibodies-in-multiple-myeloma/49264/Explore how bispecific antibodies are moving earlier in the treatment paradigm of multiple myeloma, supported by pivotal data showing improved patient outcomes.Chairperson’s Perspective: TROP2-Targeted ADCs in TNBC and HR+ mBC
https://reachmd.com/programs/cme/chairpersons-perspective-trop2-targeted-adcs-in-tnbc-and-hr-mbc/54128/This activity reviews clinical evidence and interdisciplinary strategies for integrating TROP2-targeted ADCs in TNBC and HR+ metastatic breast cancer care.Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
https://reachmd.com/programs/cme/breaking-the-line-moving-bispecific-antibodies-upstream-in-treating-multiple-myeloma/49265/Learn how early-line bispecific antibodies are reshaping multiple myeloma treatment, supported by emerging efficacy and safety data from key clinical trials.Rapidly Progressive Dementia and Plateau Waves: A Rare Presentation of Leptomeningeal Disease
https://reachmd.com/programs/practical-neurology/rapidly-progressive-dementia-and-plateau-waves-a-rare-presentation-of-leptomeningeal-disease/33145/The authors present a rare clinical marker in a patient with rapidly progressive dementia which can aid appropriate diagnostic evaluation.Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
https://reachmd.com/programs/cme/beyond-the-joint-cross-specialty-solutions-for-advancing-tgct-patient-care/36596/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.Overcoming Arising Complications in Lung Cancer Care Due to COVID-19
https://reachmd.com/programs/covid-19-frontlines/overcoming-arising-complications-in-lung-cancer-care-due-to-covid-19/11452/During this unprecedented time, how has the emergence of COVID-19 changed the practice of treating patients with lung cancer?Can We Rely on Warm Weather to Stop the Spread of COVID-19?
https://reachmd.com/programs/covid-19-frontlines/can-we-rely-on-warm-weather-to-stop-the-spread-of-covid-19/11627/Conventional wisdom tells us that warm weather will slow the spread of contagion. But based on a recent report, that may not be the case with COVID-19.Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations
https://reachmd.com/programs/Audioabstracts/impact-specialized-inpatient-ibd-care-outcomes-ibd-hospitalizations/8408/A look into the implementation of specialized inpatient IBD care for modifying short-term and long-term clinical outcomes for hospitalized patients.